Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Semaphorin 3A ELISA Kit (AC2803)
Cat.#: ASET-1392
Specifications
Description Human Semaphorin 3A ELISA Kit allows for the in vitro quantitative determination of human Semaphorin 3A concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1177 Human PCDH20 ELISA Kit (AC2588) Quantitative inquiry ASET-1589 Mouse Ki67 ELISA Kit (AC3000) Quantitative inquiry ASET-2327 Human NRP2 ELISA Kit (AC3738) Quantitative inquiry ASET-1373 Human Laminin 2 alpha ELISA Kit (AC2784) Quantitative inquiry ASET-1258 Human PCDH1 ELISA Kit (AC2669) Quantitative inquiry ASET-1774 Bovine Ghrelin ELISA Kit (AC3185) Quantitative inquiry ASET-2446 Human Tau ELISA Kit (AC3857) Quantitative inquiry ASET-2117 Human Sema6A ELISA Kit (AC3528) Quantitative inquiry ASET-1525 Human beta Catenin ELISA Kit (AC2936) Quantitative inquiry ASET-1218 Rat GAPDH ELISA Kit (AC2629) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket